NFKB1 and autoimmune hepatitis: By inhibiting the PI3K/AKT and TLRs/NF-κB signaling pathways, reducing the secretion of inflammatory factors and inhibiting hepatocyte apoptosis, thereby alleviating the inflammatory response in autoimmune hepatitis (AIH).